We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
-3.73%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$7.08B
AUM Growth
-$434M
Cap. Flow
+$37.4M
Cap. Flow %
0.53%
Top 10 Hldgs %
21.37%
Holding
240
New
5
Increased
85
Reduced
123
Closed
13

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$70.1M
2
BUD icon
AB InBev
BUD
+$16M
3
GE icon
GE Aerospace
GE
+$15.8M
4
CMCSA icon
Comcast
CMCSA
+$13M
5
LW icon
Lamb Weston
LW
+$12.6M

Sector Composition

Rank Sector Weight
1 Financials 19.81%
2 Technology 17.12%
3 Healthcare 14.64%
4 Communication Services 8.71%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
26
Chevron
CVX
$366B
$83.9M 1.18%
515,133
+5,065
+1% +$726K
AES icon
27
AES
AES
$10.5B
$82M 1.16%
3,188,498
+71,309
+2% +$1.61M
EOG icon
28
EOG Resources
EOG
$70.7B
$81.9M 1.16%
687,273
-85,944
-11% -$9.57M
KO icon
29
Coca-Cola
KO
$375B
$81.4M 1.15%
1,313,201
+20,797
+2% +$1.26M
USB icon
30
US Bancorp
USB
$99.6B
$80.5M 1.14%
1,514,947
-59,902
-4% -$3.44M
AMT icon
31
American Tower
AMT
$80.4B
$78.6M 1.11%
313,043
-7,047
-2% -$1.72M
GSK icon
32
GSK
GSK
$106B
$78.2M 1.1%
1,435,423
+41,625
+3% +$2.26M
ZBH icon
33
Zimmer Biomet
ZBH
$18.4B
$78M 1.1%
609,684
+41,230
+7% +$4.97M
RGA icon
34
Reinsurance Group of America
RGA
$16.1B
$76.2M 1.08%
696,014
+60,737
+10% +$6.72M
CVS icon
35
CVS Health
CVS
$122B
$73.7M 1.04%
728,126
+26,113
+4% +$2.74M
DIS icon
36
Walt Disney
DIS
$181B
$73.5M 1.04%
535,948
+31,969
+6% +$4.62M
SHEL icon
37
Shell
SHEL
$245B
$72.5M 1.02%
+1,320,198
New +$70.1M
MAXR
38
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$72.3M 1.02%
1,832,171
+56,740
+3% +$1.74M
IFF icon
39
International Flavors & Fragrances
IFF
$21.9B
$67.7M 0.96%
515,711
+24,416
+5% +$3.24M
ELAN icon
40
Elanco Animal Health
ELAN
$11.1B
$65.1M 0.92%
2,495,521
+135,410
+6% +$3.61M
META icon
41
Meta Platforms (Facebook)
META
$1.51T
$64.1M 0.91%
288,300
+16,396
+6% +$4.1M
CHTR icon
42
Charter Communications
CHTR
$18.2B
$63.8M 0.9%
116,947
+18,227
+18% +$10.7M
TFC icon
43
Truist Financial
TFC
$64B
$63.7M 0.9%
1,123,489
-51,112
-4% -$3.16M
XPO icon
44
XPO
XPO
$23.7B
$62.4M 0.88%
1,442,025
+131,323
+10% +$5.49M
HON icon
45
Honeywell
HON
$78B
$62.2M 0.88%
339,401
+1,763
+0.5% +$326K
JNJ icon
46
Johnson & Johnson
JNJ
$625B
$61.9M 0.87%
349,213
+37,212
+12% +$6.33M
AL
47
DELISTED
Air Lease Corp
AL
$60.5M 0.85%
1,355,727
+26,804
+2% +$1.12M
PXD
48
DELISTED
Pioneer Natural Resource Co.
PXD
$59.8M 0.84%
239,153
-34,425
-13% -$7.78M
APA icon
49
APA Corp
APA
$13.2B
$59.1M 0.83%
1,429,097
-411,388
-22% -$14.4M
GE icon
50
GE Aerospace
GE
$384B
$56.8M 0.8%
996,440
+265,577
+36% +$15.8M

Similar funds

Douglas Lane & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Douglas Lane & Associates held 240 positions worth $7.08B, down 5.8% from $7.52B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas Lane & Associates's Q1 2022 filing shows 5 new, 85 increased, 123 reduced and 13 closed positions. Its largest new stake was Shell: 1,320,198 shares worth $72.5M. The largest sale was Royal Dutch Shell PLC ADS Class B, an estimated $56.5M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

  • Douglas Lane & Associates's largest Q1 2022 buy was Shell: 1,320,198 shares worth $72.5M.
  • Douglas Lane & Associates added most to AB InBev in Q1 2022, an estimated $16M increase.
  • Douglas Lane & Associates's biggest Q1 2022 reduction was APA Corp, cutting an estimated $14.4M.
  • Douglas Lane & Associates fully exited Royal Dutch Shell PLC ADS Class B in Q1 2022, selling an estimated $56.5M.
  • Douglas Lane & Associates's ten largest holdings make up 21% of its $7.08B portfolio in Q1 2022.
  • Douglas Lane & Associates opened 5 new positions and closed 13 in Q1 2022.
  • Douglas Lane & Associates's portfolio value fell 5.8% quarter-over-quarter to $7.08B.

Based on Douglas Lane & Associates's 13F filing for Q1 2022, filed 25 Apr 2022.